#CARTcellTherapy
LightNews LightNews
pesquisafapesp.bsky.social
Conheça a terapia com células CAR-T que o Brasil desenvolve para tratar #câncer. Hemocentro da USP em Ribeirão Preto usa #linfócitos reprogramados em laboratório para combater #leucemia e #linfoma. bit.ly/VCelulasCART
Conheça a terapia com células CAR-T que o Brasil desenvolve para tratar câncer #cancer #ciencia
Hemocentro da USP em Ribeirão Preto usa linfócitos reprogramados em laboratório para combater leucemia e linfoma #cartcelltherapy #pesquisacientifica #hemocentro @CanalUSP @fapespagencia Leia reportagem: https://revistapesquisa.fapesp.br/centro-paulista-testara-em-81-pacientes-celulas-de-defesa-modificadas-para-tratar-cancer-sanguineo/
bit.ly
December 15, 2025 at 8:55 PM
fredhutch.org
Fred Hutch at #Tandem25: Catch presentations from Dr. Jennifer Adair, Elizabeth Krantz and Dr. Jennifer Huang on global access to #genetherapy, #cartcelltherapy and more. Details: bit.ly/4jW3ukj
February 15, 2025 at 5:30 PM
pesquisafapesp.bsky.social
Conheça a terapia com células CAR-T que o Brasil desenvolve para tratar #câncer. Hemocentro da USP em Ribeirão Preto usa #linfócitos reprogramados em laboratório para combater #leucemia e #linfoma. bit.ly/VCelulasCART

#oncologia
Conheça a terapia com células CAR-T que o Brasil desenvolve para tratar câncer #cancer #ciencia
Hemocentro da USP em Ribeirão Preto usa linfócitos reprogramados em laboratório para combater leucemia e linfoma #cartcelltherapy #pesquisacientifica #hemocentro @CanalUSP Leia reportagem: https://revistapesquisa.fapesp.br/centro-paulista-testara-em-81-pacientes-celulas-de-defesa-modificadas-para-tratar-cancer-sanguineo/
bit.ly
December 10, 2025 at 7:51 PM
yleyfman.bsky.social
#Oncology #CARTCellTherapy #CancerResearch #Lymphoma #Immunotherapy
March 5, 2025 at 5:42 AM
petermaccc.bsky.social
A “precision guided” CAR T-cell therapy designed at Peter Mac to kill solid tumours will progress to a first-in-human clinical trial thanks to almost $18 million from @ausgov.

More: www.petermac.org/about-us/new...

#CARTCellTherapy #Immunotherapy
July 16, 2026 at 1:00 AM
leopoldina.org
#CARTCellTherapy hat die #Immuntherapie bei Erkrankungen wie #Leukämie revolutioniert. Führende ExpertInnen haben im April 2024 an der Leopoldina u. a. weitere Einsatzmöglichkeiten CAR-basierter Therapien diskutiert. Eine Themenseite fasst die Ergebnisse zusammen:
www.leopoldina.org/wissenschaft...
January 27, 2025 at 9:56 AM
oncodaily.bsky.social
CAR T-Cell Therapy: A New Frontier in Cancer Immunotherapy

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #CARTCellTherapy #CART #Immunotherapy #IO
CAR T-Cell Therapy: A New Frontier in Cancer Immunotherapy - OncoDaily
Explore how CAR T-cell therapy works, its approved uses, challenges in solid tumors, and future innovations in precision immunotherapy.
oncodaily.com
August 2, 2025 at 9:15 PM
bmtinfonet.bsky.social
After CAR T-cell therapy, what changes should you report? Linda Ramsdell, MSN, FNP-BC, OCN, discusses follow-up health. Watch or read:

bmtinfonet.org/video/protec...

#CARTCellTherapy
BMT InfoNet 2026 Survivorship Symposium graphic for “Protecting Your Health after CAR T-cell Therapy,” with presenter Linda Ramsdell’s photo and the BMT InfoNet logo.
October 3, 2026 at 2:29 PM
onco404.bsky.social
A recent meta-analysis in JAMA Network Open evaluated cardiovascular risks in 1,528 adults receiving CAR T-cell therapy for advanced blood cancers.

@jama.com

#Onco404 #Cancer #Kanser #Hematology #CardioOncology #CARTCellTherapy #MetaAnalysis #MedResearch #MedSky #OncSky
April 28, 2025 at 10:33 AM
ascopost.bsky.social
CARTITUDE-1: Single #CARTCellTherapy infusion shows potential for cure in relapsed/refractory #MultipleMyeloma
📊 5-year PFS in 33% of patients; MRD & PET-negative in subset
📰 July cover story of The ASCO Post
👨‍⚕️ Peter M. Voorhees, MD
🔗 ascopost.com/issues/july-...
July 29, 2025 at 7:28 PM
imm.ox.ac.uk
#WIMMReads🧪
A collaboration between the #MRCWIMM and UCL presents a #CARTCellTherapy that selectively targets CALR mutated blood cancer cells while sparing healthy stem cells.

#BloodCancer #AcademicSky
@bethpsaila.bsky.social @rdm.ox.ac.uk @medsci.ox.ac.uk
New personalised therapy targets chronic blood cancer
A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving hea...
www.imm.ox.ac.uk
July 2, 2026 at 10:19 AM
pesquisafapesp.bsky.social
Conheça a terapia com células CAR-T que o Brasil desenvolve para tratar #câncer. Hemocentro da USP em Ribeirão Preto usa #linfócitos reprogramados em laboratório para combater #leucemia e #linfoma. bit.ly/VCelulasCART

#oncologia
Conheça a terapia com células CAR-T que o Brasil desenvolve para tratar câncer #cancer #ciencia
Hemocentro da USP em Ribeirão Preto usa linfócitos reprogramados em laboratório para combater leucemia e linfoma #cartcelltherapy #pesquisacientifica #hemocentro @CanalUSP Leia reportagem: https://revistapesquisa.fapesp.br/centro-paulista-testara-em-81-pacientes-celulas-de-defesa-modificadas-para-tratar-cancer-sanguineo/
bit.ly
December 8, 2025 at 7:23 PM
genesdev.bsky.social
REVIEW: Aging and immunity: the age-old tango
by Fernández Maestre et al. @corina-amor.bsky.social‬ @cshlaboratory.bsky.social‬
➡️ https://tinyurl.com/gd352644
##aging #senescence #cancer #immuneregulation #antiaging #immunotherapy #CancerImmunotherapy #Inflammaging #CARTCellTherapy #CART
August 8, 2025 at 3:29 PM
onco404.bsky.social
A recent study highlights bispecific antibodies #BsAbs as a powerful bridging therapy before BCMA CAR-T cell treatment for relapsed/refractory multiple myeloma #RRMM

@theaacr.bsky.social #bcd_aacr

#Onco404 #Cancer #Kanser #MultipleMyeloma #CARTCellTherapy #MedSky #Immunotherapy #Hematology
May 13, 2025 at 4:23 PM
markflower.bsky.social
A reason to be optimistic #CARTcellTherapy #CARTcells #celltherapy
Moffitt Patient Is First To Receive Second CAR T Therapy for Ovarian Cancer
The FDA gave special approval to treat single patient with second dose of cellular immunotherapy
www.moffitt.org
November 19, 2024 at 11:11 PM
yleyfman.bsky.social
#CARTCellTherapy #Immunotherapy #CellTherapyRevolution #CancerImmunotherapy #AdvancedCancerCare #CARTCellResearch #NextGenTherapies #BiotechBreakthrough #CancerResearch #InnovativeMedicine #BloodCancerTreatment #MultipleMyelomaCare #LymphomaAwareness #LeukemiaSupport
December 15, 2024 at 3:49 PM
imfmyeloma.bsky.social
Multiple myeloma research is moving fast. Dr. Joseph Mikhael breaks down key ASCO and EHA 2026 findings on bispecifics, CELMoDs, belantamab, and in vivo CAR T—and what they could mean for patients and families. Watch now 👉 https://mmsm.link/4f7GQUv

#AsktheIMF #mmsm #cartcelltherapy
July 10, 2026 at 2:09 PM
hospidio.com
The process of engineering the patient's own T-cells often takes 2–3 weeks. Despite this time-intensive process, autologous CAR T-cells are highly personalized, reducing the risk of rejection compared to donor-derived cells. Read more here: shorturl.at/O1QGF

#cartcelltherapy #lymphoma #leukemia
January 21, 2025 at 10:50 AM
itmat.bsky.social
Broadening clinical utility of #CARTcelltherapy through in vivo engineering targeted lipid nanoparticles (tLNPs) for messenger RNA delivery to specific T cell subsets doi.org/10.1126/scie... @carlhjune @Haig_Ag #CellTherapy #CARTCell #TranslationalScience
In vivo CAR T cell generation to treat cancer and autoimmune disease
Chimeric antigen receptor (CAR) T cell therapies have transformed treatment of B cell malignancies. However, their broader application is limited by complex manufacturing processes and the necessity f...
doi.org
June 26, 2025 at 1:08 PM
gmj-georgia.bsky.social
🧬 CAR T cell therapy induces deep remissions in smoldering myeloma—an asymptomatic cancer precursor—but causes severe toxicities in ~48% of patients, according…

#CARTcelltherapy #Immunotherapy #Oncology #Patientselection #Precancer

#CARTcelltherapy #Immunotherapy #Oncology #Patientselection #Pr…
CAR T Cells Show Efficacy but Severe Toxicity in Smoldering Myeloma
🧬 CAR T cell therapy induces deep remissions in smoldering myeloma—an asymptomatic cancer precursor—but causes severe toxicities in ~48% of patients, according… #CARTcelltherapy #Immunotherapy #Oncology #Patientselection #Precancer
news.gmj.ge
July 12, 2026 at 3:52 AM
clarinetsax.bsky.social
Why do 80% of eligible patients miss out on life-saving #CARTCellTherapy?

www.CancerSupportCommunty.org's research reveals real barriers—financial toxicity, travel burden, caregiver strain—that keep patients from accessing CAR T.
#Tandem26, ⏰ 6:30-8p, 📅 Th, 2/5

#CART #HealthEquity
bit.ly/3LRWDwh
Scientific poster explaning the findings - CONCLUSION For patients and caregivers, travel time and cost , difficulties with care coordination, securing a 24/7 caregiver, and the perceived risk of side effects are the most significant barriers to CAR T. • Having to travel long distances to academic cancer centers away from patients’ primary care sites for CAR T cell therapy compounded the psychosocial and financial burden associated with receiving CAR T for patients and caregivers. • The time, financial, and social toxicity associated with CAR T cell therapy impacts patients, caregivers, families, and communities. • CAR T should be made available at more care sites and supportive resources should be made more widely available to reduce the financial, logistic, and psychosocial burden of CAR T and improve access to this innovative therapy
February 4, 2026 at 9:35 PM
irat1onal.bsky.social
Turning All Cancers Into Curable Diseases - Dr. Karen Knudsen MBA PhD - CEO, Parker Institute for Cancer Immunotherapy, joins me on Progress, Potential, And Possibilities #ProstateCancer #CARTCellTherapy #CheckpointInhibitors #TumorAntigens #TumorMicroenvironment www.youtube.com/watch?v=cyrO...
Dr. Karen Knudsen - CEO, Parker Institute for Cancer Immunotherapy - Turning All Cancers Curable
YouTube video by Progress, Potential, and Possibilities
www.youtube.com
September 19, 2025 at 8:49 PM
itmat.bsky.social
Refining first-in-human dual-targeting chimeric antigen receptor (CAR)-T cells for #Glioblastoma with real-time #Organoid modeling. doi.org/10.1016/j.st... #Cancer #CARTcelltherapy #TranslationalScience
January 28, 2025 at 6:12 PM
societyofhemonc.bsky.social
Is CAR T-cell therapy 'enough,' or does the patient still need a transplant after? Two SOHO experts hash it out. Full episode of SOHO Spotlight 👇
soho.click/soho-spotlig...
#SOHOSpotlight #HematologicOncology #CARTCellTherapy #ALL
September 18, 2026 at 5:17 PM
panbello.bsky.social
R.I.P., Zelig #Eshhar [°Feb. 25, 1941 – July 3, 2025]🕯️🫡🌹

#Immunotherapy #cancer #Tcells #CART #CARTcellTherapy #IchilovHospital #DepartmentofImmunology #WeizmannInstituteofScience #BarujBenacerraf #GideonGross #StevenRosenberg #ScottGottlieb #NomiFriedlander #ZeligLipka #ZeligEshhar
July 24, 2025 at 7:43 AM